Vimarsana
Biggest News Aggregation in the World

Page 13 - Wall Street Transcript News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wall Street Transcript. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wall Street Transcript Today - Breaking & Trending Today

Steve Brozak Wants MASP-2 Targeting for COVID 19 Treatment - Vimarsana News

Steve Brozak Wants MASP-2 Targeting for COVID 19 Treatment

Steve Brozak is the Managing Partner and President of WBB Securities and is a Wall Street Journal’s “Best on the Street” analyst.

Source: twst.com
Mesoblast Limited (NASDAQ:MESO) CEO Silviu Itescu Says Stock Price Blast Off is Imminent - Vimarsana News

Mesoblast Limited (NASDAQ:MESO) CEO Silviu Itescu Says Stock Price Blast Off is Imminent

The current status of Mesoblast Limited (NASDAQ:MESO) allogeneic cell therapy in an interview with the CEO Silviu Itescu.

Source: twst.com
Chardan Analyst: Gene Therapy Stocks Start their Long Ride to the Upside - Vimarsana News

Chardan Analyst: Gene Therapy Stocks Start their Long Ride to the Upside

Chardan Analyst Geulah Livshits, PhD, picks the top gene therapy stocks to buy for investors for 2021 and beyond.

Source: twst.com
Autolus Therapeutics (NASDAQ:AUTL) is a Top Pick from William Blair's Matt Phipps, Ph.D. - Vimarsana News

Autolus Therapeutics (NASDAQ:AUTL) is a Top Pick from William Blair's Matt Phipps, Ph.D.

Autolus Therapeutics (NASDAQ:AUTL) is a Top Pick from William Blair's Matt Phipps, Ph.D., the StarMine No.1 biotechnology earnings estimator

Source: twst.com
John Heffern of KCA/Princeton Advisors Wants to Do Better than an ETF - Vimarsana News

John Heffern of KCA/Princeton Advisors Wants to Do Better than an ETF

John Heffern is Principal and Founder of KCA/Princeton Advisors. His career includes nearly 30 years of senior level portfolio management.

Source: twst.com